KOREA UNITED PHARM INC
033270 | KO
Overview
Corporate Details
- ISIN(s):
- KR7033270000
- LEI:
- Country:
- South Korea
- Address:
- 세종특별자치시 전동면 노장리 404-10, 세종특별자치시
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-18 00:00 |
Regulatory Filings
[기재정정]투자판단관련주요경영사항
|
Korean | 18.9 KB | ||
| 2025-09-09 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.0 KB | ||
| 2025-09-09 00:00 |
Regulatory Filings
투자판단관련주요경영사항
|
Korean | 10.6 KB | ||
| 2025-08-28 00:00 |
Regulatory Filings
투자판단관련주요경영사항
|
Korean | 8.2 KB | ||
| 2025-08-13 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 1009.4 KB | ||
| 2025-07-28 00:00 |
Annual Report
[기재정정]사업보고서 (2024.12)
|
Korean | 1.2 MB | ||
| 2025-07-28 00:00 |
Earnings Release
영업(잠정)실적(공정공시)
|
Korean | 13.3 KB | ||
| 2025-06-25 00:00 |
Transaction in Own Shares
신탁계약에의한취득상황보고서
|
Korean | 20.2 KB | ||
| 2025-06-18 00:00 |
Report Publication Announcement
기업설명회(IR)개최(안내공시)
|
Korean | 6.1 KB | ||
| 2025-05-14 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1010.9 KB | ||
| 2025-04-29 00:00 |
Earnings Release
영업(잠정)실적(공정공시)
|
Korean | 13.3 KB | ||
| 2025-04-22 00:00 |
Major Shareholding Notification
최대주주등소유주식변동신고서
|
Korean | 58.4 KB | ||
| 2025-04-22 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.3 KB | ||
| 2025-04-22 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 159.6 KB | ||
| 2025-03-25 00:00 |
Share Issue/Capital Change
주식매수선택권부여에관한신고
|
Korean | 15.5 KB |
Automate Your Workflow. Get a real-time feed of all KOREA UNITED PHARM INC filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for KOREA UNITED PHARM INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for KOREA UNITED PHARM INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Develops and manufactures pharmaceuticals for rare diseases and unmet health needs globally.
Türkiye
GENIL
Türkiye
GENIL
Creates and develops antibody therapeutics for the treatment of cancer and serious diseases.
Denmark
GMAB
Denmark
GMAB
Develops molecular diagnostic and RNAi solutions for genetic testing and life sciences research.
South Korea
225220
South Korea
225220
Clinical-stage biopharma developing cancer therapies using microbiome, immune inhibitors, and ADCs.
South Korea
314130
South Korea
314130
Develops a mobile platform for rapid, precise genetic diagnostics at the point-of-care.
Poland
GMT
Poland
GMT
A biotech firm offering gene synthesis, genome analysis, and biopharmaceutical products globally.
South Korea
066830
South Korea
066830
Developing gene therapies for neurodegenerative diseases of the eye and central nervous system.
France
SIGHT
France
SIGHT
Develops & manufactures IVD immunoassays for human & veterinary disease diagnostics.
Norway
GENT
Norway
GENT
Commercializes an approved, first-in-class telomerase inhibitor for blood cancers.
United States of America
GERN
United States of America
GERN
Develops innovative medicines for life-threatening diseases in virology, oncology & inflammation.
United States of America
GILD
United States of America
GILD